An influential US medical journal, the Annals of Internal Medicine, has rejected a call from Robert F. Kennedy Jr., the Secretary of the Department of Health and Human Services, to retract a large Danish study. The study, published in July and funded by the Danish government, found no evidence that aluminum ingredients in vaccines increase health risks for over 1.2 million children over two decades. Kennedy, a prominent vaccine skeptic, labeled the research as a "deceitful propaganda stunt" and criticized its methodology, including the lack of a control group and the alleged exclusion of certain child groups. However, the journal's editor-in-chief and the study's lead author firmly defended the research, stating there was "no reason for retraction" and no evidence of scientific misconduct, while addressing Kennedy's critiques regarding study design and data access.
Key Developments Regarding Vaccine Study Retraction Request:
Journal Rejects Retraction: The Annals of Internal Medicine, a prominent US medical journal, has rejected a request from Secretary of Health and Human Services, Robert F. Kennedy Jr., to retract a Danish vaccine study.
RFK Jr.'s Stance: As HHS Secretary, Robert F. Kennedy Jr. (RFK Jr.) has consistently promoted doubts about vaccine safety and efficacy. He is reportedly considering a review of aluminum-containing vaccines, linking them to autoimmune diseases and allergies.
The Danish Study Findings: A large-scale Danish government-funded study, published in July, analyzed over 1.2 million children's data spanning two decades. It concluded that aluminum in vaccines does not increase the risk of autoimmune, atopic/allergic, or neurodevelopmental disorders.
Expert Endorsement: Childhood vaccination expert Adam Finn praised the Danish study as "the best available evidence" on aluminum safety in vaccines, citing its "solid, massive dataset and high-quality data."
RFK Jr.'s Criticism: RFK Jr. harshly criticized the study, calling it a "deceitful propaganda stunt by the pharmaceutical industry" and claiming it was "meticulously designed...not to find harm." He demanded its immediate retraction in an opinion piece on TrialSite News.
Journal's Defense: Dr. Christine Laine, editor-in-chief of the Annals of Internal Medicine, stated there was "no reason for retraction" and affirmed that Kennedy's concerns, while possibly highlighting acceptable limitations, "do not invalidate what they found, and there’s no evidence of scientific misconduct." The journal plans to respond to general criticism on its website.
Study Author's Rebuttal: Anders Peter Hviid, the study's lead author, defended his work on TrialSite, refuting Kennedy's critiques as unsubstantive and denying any deceit. He clarified that a control group was not feasible due to Denmark's 2% unvaccinated population, and individual-level data, while available for research, is not publicly released under Danish law.
Political Targeting: Hviid expressed that he has "not been targeted by a political figurehead in this way before," highlighting the unusual nature of the criticism.
HHS Response: A spokesperson for the Department of Health and Human Services stated they had "no further comment than what the secretary said."